SEQENS Group products

Ammonium lactate is an inorganic salt used for the symptomatic treatment of dry, scaly skin (xerosis) and ichthyosis vulgaris and for temporary relief of itching associated with these conditions.

Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast cancer.

Cetirizine is an orally active second-generation histamine H1 antagonist proven effective in the treatment of various allergic symptoms, such as sneezing, coughing, nasal congestion, hives, and other symptoms. Cetirizine used for a condition called allergic rhinitis. Cetirizine is one of the first second-generation H1 antihistamines (SGAHs) formulated to selectively inhibit the H1 receptor without sedating effects.

Cilostazol, a quinolinone derivative, is a cellular phosphodiesterase inhibitor, more specific for phosphodiesterase III (PDE III). Cilostazol inhibits platelet aggregation and widens arteries (direct arterial vasodilator). Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation.

Cisatracurium is a nondepolarizing skeletal muscle relaxant for intravenous administration. Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. Cisatracurium is one of the ten isomers of the parent molecule, atracurium. Cisatracurium represents approximately 15% of the atracurium mixture.

Seqens provides active Pharmaceutical Ingredient (API) and drug substance development services. We support emerging and large pharmaceutical customers in human and animal health with their pharmaceutical and biotechnology applications for complex, niche and small molecule programs through two main R&D locations in the regions of Boston and Paris.

Our Drug Delivery Solutions Business Unit coordinates our Custom Polymers activity. Seqens strongly believes in the potential of new cutting-edge technologies. In the pharmaceutical industry, lipids and polymers are core excipients in the development of drug delivery systems. Lipids and polymers can be used in most dosage forms as support vehicles, solubilizers, permeation enhancers, stabilizers, transfection agents and release rate modifiers.

Our Drug Delivery Solutions Business Unit coordinates our Custom Lipids activity. Seqens strongly believes in the potential of new cutting-edge technologies. In the pharmaceutical industry, lipids and polymers are core excipients in the development of drug delivery systems. Lipids and polymers can be used in most dosage forms as support vehicles, solubilizers, permeation enhancers, stabilizers, transfection agents and release rate modifiers.

Efinaconazole is an anti-fungal agent. It is formulated as solution for topical application.

Undisputed leader of Acetyl salicylic acid, Seqens EDS benefits from the favorable localization of the different GMP sites ; only 40 km between its salicylic acid and acetyl salicylic plants, both located in France. A short distribution circuit for an effective and flexible production.